StockMacro
Company, fund or insider

Help

Menu

Eric Schwartz

Insider (Form 4 reporting owner): EVP, Chief Legal Officer & Sec CIK 1329100Name as filed: Schwartz EricIts filings on EDGARAll insiders

Measures activity, not value. Not investment advice.

Since 28 Mar 2018, sold $2.5M in 6 sales and bought $100K in 1 open-market purchase across 2 companies.

Companies

Role on the latest Form 4 for each; open-market trades counted
CompanyRoleTrades fromtoPurchasesSales
Globus Medical GMEDSenior VP and General Counsel28 Mar 201825 Jun 2018–2$1.7M
Integra LifeSciences IARTEVP, Chief Legal Officer & Sec5 Dec 20193 Dec 20241$100K4$797K

What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.

Median return minus the sector fund, in percentage points; "too few trades" under 5
Open-market tradesAfter 3 monthsAfter 6 monthsAfter 12 months
After purchasestoo few trades1 tradetoo few trades1 tradetoo few trades1 trade
After sales+0.5 pts5 trades, 80% above the sector-8.8 pts5 trades, 0.00% above the sector-22.6 pts5 trades, 40% above the sector

For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.

By year

Counted open-market trades, by trade date
YearPurchasesBoughtSalesSoldNet
2024––1$100K-$100K
20231$100K––$100K
2021––2$450K-$450K
2019––1$247K-$247K
2018––2$1.7M-$1.7M

Every trade

7, newest first; open-market purchases and sales only
Trade dateCompanySideSharesPriceValuePlanned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. Filing
3 Dec 2024Integra LifeSciences IARTSell4,070$24.60$100KNoForm 4filed 4 Dec 2024
1 Jun 2023Integra LifeSciences IARTBuy2,640$37.89$100KNoForm 4filed 5 Jun 2023
2 Mar 2021Integra LifeSciences IARTSell4,212$69.10$291KNot statedForm 4filed 3 Mar 2021
25 Feb 2021Integra LifeSciences IARTSell2,288$69.52$159KNot statedForm 4filed 1 Mar 2021
5 Dec 2019Integra LifeSciences IARTSell4,007$61.62$247KNot statedForm 4filed 5 Dec 2019
25 Jun 2018Globus Medical GMEDSellafter exercising options10,000$53.79$538KNot statedForm 4filed 27 Jun 2018
28 Mar 2018Globus Medical GMEDSellafter exercising options24,000$50.00$1.2MNot statedForm 4filed 30 Mar 2018

From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.